{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:53:31Z","timestamp":1787648011884,"version":"build-2736575974"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,5,1]]},"abstract":"<jats:p>Severe<jats:italic>Strongyloides stercoralis<\/jats:italic>, such as hyperinfection syndrome, carries a high mortality risk. Even with appropriate treatment, patients may experience infectious complications and failure of therapy. Currently, there are no Food and Drug Administration\u2013approved parenteral therapies available for treatment in patients who develop gastrointestinal complications from hyperinfection, including small bowel obstruction. A veterinary form of ivermectin is available as a subcutaneous injection, although current literature in humans is limited. We report on the successful treatment of two surviving immunocompromised patients with<jats:italic>S. stercoralis<\/jats:italic>hyperinfection syndrome after prompt recognition and initiation of veterinary subcutaneous ivermectin therapy.<\/jats:p>","DOI":"10.1136\/bcr-2017-223138","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:35:05Z","timestamp":1528115705000},"page":"bcr-2017-223138","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Successful use of subcutaneous ivermectin for the treatment of<i>Strongyloides stercoralis<\/i>hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population"],"prefix":"10.1136","volume":"2018","author":[{"given":"Kristen","family":"Zeitler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripal","family":"Jariwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Restrepo-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Casanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Alrabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrapol","family":"Sriaroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.1","doi-asserted-by":"publisher","DOI":"10.1086\/322707"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.2","first-page":"766","article-title":"Strongyloides stercoralis hyperinfection syndrome and disseminated disease","volume":"7","author":"Kassalik","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.3","unstructured":"Centers for Disease Control and Prevention. Epidemiology &risk factors. https:\/\/www.cdc.gov\/parasites\/strongyloides\/epi.html (accessed 8 Feb 2017)."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2009.10.009"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.5","unstructured":"Centers for Disease Control and Prevention. Strongyloidiasis. https:\/\/www.cdc.gov\/dpdx\/strongyloidiasis\/index.html (accessed 18 Feb 2017)."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.6","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7961-4-8"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.208-217.2004"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.8","unstructured":"Stromectol [package insert]. Whitehouse Station. NJ: Merck & Co, Inc, 2010."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.9","doi-asserted-by":"publisher","DOI":"10.1086\/430827"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv315"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.11","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0750"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.12","unstructured":"Centers for Disease Control and Prevention. Resources for Health Professionals. https:\/\/www.cdc.gov\/parasites\/strongyloides\/health_professionals\/index.html (accessed 8 Feb 2017)."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.13","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283551dbd"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.14","first-page":"363","article-title":"Fatal Strongyloides stercoralis infection in a patient receiving corticosteroids","volume":"146","author":"Yee","year":"1987","journal-title":"West J Med"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.15","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90371-K"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.16","doi-asserted-by":"publisher","DOI":"10.1179\/2047773211Y.0000000006"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.17","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0799-1"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2012.08.008"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.19","unstructured":"IVOMEC. Package insert. Duluth, GA: Merial Limited, 2010."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.20","unstructured":"Williams MJ . U.S. Patent No. 4, 853, 372. Rahway, NJ: U.S, 1989."},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.21","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0077"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.22","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.10-0258"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4269\/ajtmh.2008.79.853","article-title":"Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection","volume":"79","author":"Leung","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.24","doi-asserted-by":"publisher","DOI":"10.3109\/00365540903443165"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","author":"Turner","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2025042703455059000_2018.jun01_1.bcr-2017-223138.26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40475-014-0032-9","article-title":"Immune Response to Infection with Strongyloides stercoralis in Patients with Infection and Hyperinfection","volume":"1","author":"Weatherhead","year":"2014","journal-title":"Curr Trop Med Rep"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-223138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:46:06Z","timestamp":1745750766000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-223138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":26,"alternative-id":["10.1136\/bcr-2017-223138"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-223138","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]}}}